Patients with diabetes without significant angiographic coronary artery diseasehave the same risk of myocardial infarction as patients without diabetes in a real-world population receiving appropriate prophylactic treatment

Diabetes Care

Volumn 40, Issue 8, 2017, Pages 1103-1110

  Olesen, Kevin K W ^a   Madsen, Morten ^a   Egholm, Gro ^a   Thim, Troels ^a   Jensen, Lisette O ^b   Raungaard, Bent ^c   Bøtker, Hans E ^a   Sørensen, Henrik T ^a   Maeng, Michael ^a  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; COHORT ANALYSIS; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEART INFARCTION; HUMAN; MALE; MIDDLE AGED; REGISTER; RISK FACTOR;

AGED; ASPIRIN; COHORT STUDIES; COMORBIDITY; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; DENMARK; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; REGISTRIES; RISK FACTORS;

EID: 85028042999     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc16-2388     Document Type: Conference Paper

References (30)

1. Fox CS, Golden SH, Anderson C, et al.; American Heart Association Diabetes Committee of the Council on Lifestyle and Cardiometabolic Health, Council on Clinical Cardiology, Council on Cardiovascular and Stroke Nursing, Council on Cardiovascular Surgery and Anesthesia, Council on Quality of Care and Outcomes Research; American Diabetes Association. Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association. Circulation 2015;132:691-718
2. Haffner SM, Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234
3. Lee CD, Folsom AR, Pankow JS, Brancati FL; Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and nondiabetic adults with or without history of myocardial infarction. Circulation 2004;109: 855-860
4. Evans JM, Wang J, Morris AD. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. BMJ 2002;324:939-942
5. Lotufo PA,Gaziano JM, ChaeCU, et al.Diabetes and all-cause and coronary heart disease mortality among US male physicians. Arch Intern Med 2001;161:242-247
6. Hu G, Jousilahti P, Qiao Q, PeltonenM, Katoh S, Tuomilehto J. The gender-specific impact of diabetes and myocardial infarction at baseline and during follow-up on mortality from all causes and coronary heart disease. J AmColl Cardiol 2005;45: 1413-1418
7. Eberly LE, Cohen JD, Prineas R, Yang L; Intervention Trial Research Group. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-yearmortality: the multiple risk factor intervention trial experience. Diabetes Care 2003; 26:848-854
8. Hu FB, Stampfer MJ, Solomon CG, et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch Intern Med 2001; 161:1717-1723
9. Cho E, Rimm EB, Stampfer MJ, Willett WC, Hu FB. The impact of diabetesmellitus and priormyocardial infarction on mortality from all causes and from coronary heart disease in men. J Am Coll Cardiol 2002;40:954-960
10. Wannamethee SG, Shaper AG, Lennon L. Cardiovascular disease incidence and mortality in older men with diabetes and in men with coronary heart disease. Heart 2004;90:1398-1403
11. American Diabetes Association. Cardiovascular disease and risk management. Sec. 9. In Standards ofMedical Care in Diabetesd2017. Diabetes Care 2017;40(Suppl. 1):S75-S87
12. Rydén L, Grant PJ, Anker SD, et al.; Task Force on Diabetes, Pre-Diabetes, and Cardiovascular Diseases of the European Society of Cardiology (ESC); European Association for the Study of Diabetes (EASD). ESC guidelines on diabetes, prediabetes, and cardiovascular diseases developed in collaboration with the EASD-summary. Diab Vasc Dis Res 2014;11:133-173
13. Schmidt M, Maeng M, Jakobsen CJ, et al. Existing data sources for clinical epidemiology: the Western Denmark Heart Registry. Clin Epidemiol 2010;2:137-144
14. Lynge E, Sandegaard JL, ReboljM. The Danish National Patient Register. Scand J Public Health 2011;39(Suppl. 7):30-33
15. Juel K, Helweg-Larsen K. The Danish registers of causes of death. DanMed Bull 1999;46:354-357
16. Johannesdottir SA, Horváth-Puhó E, Ehrenstein V, Schmidt M, Pedersen L, Sørensen HT. Existing data sources for clinical epidemiology: the Danish National Database of Reimbursed Prescriptions. Clin Epidemiol 2012;4:303-313
17. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383
18. Egholm G, Madsen M, Thim T, et al. Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention. Clin Epidemiol 2016;8: 415-423
19. Zou G. A modified Poisson regression approach to prospective studies with binary data. Am J Epidemiol 2004;159:702-706
20. Jensen LO, Thayssen P, Junker A, et al. Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus-and sirolimus-eluting stents (fromthe SORT OUT IV trial). Am J Cardiol 2012;110:1585-1591
21. Olesen KK, Tilsted HH, Jensen LO, et al. Long-term outcome of sirolimus-eluting and zotarolimus-eluting coronary stent implantation in patients with and without diabetes mellitus (a Danish organization for randomized trials on clinical outcome III substudy). Am J Cardiol 2015;115:298-302
22. Nicholls SJ, Tuzcu EM, Crowe T, et al. Relationship between cardiovascular risk factors and atherosclerotic disease burden measured by intravascular ultrasound. J Am Coll Cardiol 2006; 47:1967-1975
23. Nanchen D, Rodondi N, Cornuz J, et al.; Study of Osteoporotic Fractures Research Group. Mortality associated with diabetes and cardiovascular disease in olderwomen. PLoSOne 2012;7:e48818
24. Bulugahapitiya U, Siyambalapitiya S, Sithole J, Idris I. Is diabetes a coronary risk equivalent? Systematic review and meta-analysis. Diabet Med 2009;26:142-148
25. Saely CH, Aczel S,Marte T, Langer P, Drexel H. Cardiovascular complications in type 2 diabetes mellitus depend on the coronary angiographic state rather than on the diabetic state. Diabetologia 2004;47:145-146
26. Malik S, Budoff MJ, Katz R, et al. Impact of subclinical atherosclerosis on cardiovascular disease events in individuals with metabolic syndrome and diabetes: the multi-ethnic study of atherosclerosis. Diabetes Care 2011;34:2285-2290
27. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ 1998;317:703-713
28. Zoungas S, Chalmers J, Neal B, et al.; ADVANCE-ON Collaborative Group. Follow-up of blood-pressure lowering and glucose control in type 2 diabetes. N Engl J Med 2014;371:1392-1406
29. Kearney PM, Blackwell L, Collins R, et al.; Cholesterol Treatment Trialists' (CTT) Collaborators. Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis. Lancet 2008; 371:117-125
30. National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III) final report. Circulation 2002;106: 3143-3421